Iksuda Therapeutics

Iksuda Therapeutics focuses on developing antibody-drug conjugates (ADCs) with enhanced tumor specificity for difficult-to-treat cancers. They have a research and development team working on a pipeline of ADCs aimed at anti-cancer effectiveness and patient outcomes.
  • Bioconjugation technologies
  • Antibody-drug conjugates (ADCs)
  • Tumour-selective payload activation
Size
Small
Phone
N/A
Website
iksuda.com
Email
N/A
Locations
Draymans Wy, NE4 5BX
01916031680
9:00 - 17:00
Digital Popularity
Popularity over time
Social Media
Company Details
Iksuda Therapeutics is operated by Iksuda Therapeutics Limited and is a Active company incorporated on 21 November 2007 with the registered office located in . Iksuda Therapeutics Limited was registered 18 years ago.
Status
Active
Size
Micro
Directors
5
Age
18 years old
Employees
37
Turnover
Unreported
Total Assets
£17.69M
Cash in Bank
£9.29M
Total Liabilities
-£46.26M
Dr Jose Ponte
Director • American • Lives in United States • Born in Mar 1971
Se Jin Park
Director • Chief Financial Officer And Director • South Korean • Lives in South Korea • Born in Mar 1962
Yong Zu Kim
Director • Chief Executive Officer And Director • South Korean • Lives in South Korea • Born in May 1956
Dr David John Simpson
Director • Chief Executive Officer • British • Lives in UK • Born in Dec 1972
More information on Iksuda Therapeutics Limited